Evidence map›Paper›PMID 31877896›Full record

ArticleCancers2019

Application of an Artificial Intelligence Algorithm to Prognostically Stratify Grade II Gliomas.

Daniela Cesselli, Tamara Ius, Miriam Isola, Fabio Del Ben, Giacomo Da Col, Michela Bulfoni, Matteo Turetta, Enrico Pegolo, Stefania Marzinotto, Cathryn Anne Scott and 4 more

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniela CesselliDepartment of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-0562-7852
Tamara IusDepartment of Neurosurgery, University Hospital of Udine, 33100 Udine, Italy.
Miriam IsolaDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Fabio Del BenDepartment of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-1880-0669
Giacomo Da ColSISSA (Scuola Internazionale Superiore di Studi Avanzati), 34136 Trieste, Italy.
Michela BulfoniDepartment of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Matteo TurettaImmunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano (PN), Italy.ORCID 0000-0001-6446-6764
Enrico PegoloDepartment of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Stefania MarzinottoDepartment of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Cathryn Anne ScottDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Laura MariuzziDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Carla Di LoretoDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Antonio Paolo BeltramiDepartment of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-0679-2710
Miran SkrapDepartment of Neurosurgery, University Hospital of Udine, 33100 Udine, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Recently, it has been shown that the extent of resection (EOR) and molecular classification of low-grade gliomas (LGGs) are endowed with prognostic significance. However, a prognostic stratification of patients able to give specific weight to the single parameters able to predict prognosis is still missing. Here, we adopt classic statistics and an artificial intelligence algorithm to define a multiparametric prognostic stratification of grade II glioma patients. (2) Methods: 241 adults who underwent surgery for a supratentorial LGG were included. Clinical, neuroradiological, surgical, histopathological and molecular data were assessed for their ability to predict overall survival (OS), progression-free survival (PFS), and malignant progression-free survival (MPFS). Finally, a decision-tree algorithm was employed to stratify patients. (3) Results: Classic statistics confirmed EOR, pre-operative- and post-operative tumor volumes, Ki67, and the molecular classification as independent predictors of OS, PFS, and MPFS. The decision tree approach provided an algorithm capable of identifying prognostic factors and defining both the cut-off levels and the hierarchy to be used in order to delineate specific prognostic classes with high positive predictive value. Key results were the superior role of EOR on that of molecular class, the importance of second surgery, and the role of different prognostic factors within the three molecular classes. (4) Conclusions: This study proposes a stratification of LGG patients based on the different combinations of clinical, molecular, and imaging data, adopting a supervised non-parametric learning method. If validated in independent case studies, the clinical utility of this innovative stratification approach might be proved.

Indexed as

artificial intelligencedecision treesextent of resectiongrade II gliomamolecular classificationMRI dataprognosis

Identifiers

PMID31877896
PMCPMC7016715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.